| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.26 | 7e-13 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-12 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-08 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-08 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-08 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-07 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-07 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-07 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-07 |